Patents by Inventor Kjell Fuxe

Kjell Fuxe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4138484
    Abstract: A method for treating schizophrenia and a method and composition for potentiating the beneficial effects and reducing the side effects of neuroleptic drugs. Schizophrenia is treated with a GABA-like compound such as Lioresal. Neuroleptic drugs are potentiated by coadministering to a schizophrenic a neuroleptic drug and a GABA-like drug such as Lioresal.
    Type: Grant
    Filed: July 25, 1977
    Date of Patent: February 6, 1979
    Assignee: Nelson Research & Development Company
    Inventor: Kjell Fuxe
  • Patent number: 4129652
    Abstract: A method for treating schizophrenia and a method and composition for potentiating the beneficial effects and reducing the side effects of neuroleptic drugs. Schizophrenia is treated with a GABA-like compound such as Lioresal. Neuroleptic drugs are potentiated by coadministering to a schizophrenic a neuroleptic drug and a GABA-like drug such as Lioresal.
    Type: Grant
    Filed: July 25, 1977
    Date of Patent: December 12, 1978
    Assignee: Nelson Research & Development Company
    Inventor: Kjell Fuxe
  • Patent number: 4084000
    Abstract: A method for treating schizophrenia and a method and composition for potentiating the beneficial effects and reducing the side effects of neuroleptic drugs. Schizophrenia is treated with a GABA-like compound such as Lioresal. Neuroleptic drugs are potentiated by coadministering to a schizophrenic a neuroleptic drug and a GABA-like drug such as Lioresal.
    Type: Grant
    Filed: August 16, 1976
    Date of Patent: April 11, 1978
    Assignee: Nelson Research and Development Company
    Inventor: Kjell Fuxe
  • Patent number: 3991198
    Abstract: Methods of temporarily alleviating symptoms of hypersomnia or mental fatigue or drowsiness or temporarily suppressing appetite by administering to a human or animal having one or more of the aforementioned symptoms an effective amount of piperoxan together with a suitable pharmaceutical carrier. Piperoxan is also useful for potentiating the effects of anti-depressant drugs.
    Type: Grant
    Filed: June 25, 1975
    Date of Patent: November 9, 1976
    Assignee: Nelson Research & Development Company
    Inventor: Kjell Fuxe
  • Patent number: 3978216
    Abstract: A method for treating schizophrenia and a method and composition for potentiating the beneficial effects and reducing the side effects of neuroleptic drugs. Schizophrenia is treated with a GABA-like compound such as Lioresal. Neuroleptic drugs are potentiated by coadministering to a schizophrenic a neuroleptic drug and a GABA-like drug such as Lioresal.
    Type: Grant
    Filed: July 16, 1975
    Date of Patent: August 31, 1976
    Assignee: Nelson Research & Development Company
    Inventor: Kjell Fuxe
  • Patent number: 3947579
    Abstract: A method and composition for potentiating the effects of neuroleptic drugs by administering to a human having a disorder normally treatable with a neuroleptic drug, a neuroleptic drug in combination with a potentiating amount of an amino acid of the formula ##SPC1##Where R is fluorine, chlorine, bromine or trifluoromethyl and their salts.
    Type: Grant
    Filed: June 3, 1974
    Date of Patent: March 30, 1976
    Assignee: Nelson Research & Development Company
    Inventor: Kjell Fuxe